← Leaderboards
Michael George Constantinides
Scripps Research Institute, The
$2,130,625
Attributed
$2,130,625
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $674.4K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,130,625 · 3
By mechanism
R35$1,372,500 · 1
R21$488,125 · 1
K22$270,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- Douglas A Lauffenburger$27,665,222
Others in their field
Other Emerging Leaders on “Cytokine”
- Thomas Denny · Duke University$22,999,550
- Valerie Fremont · Quality Biological, Inc.$19,261,930
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
- Amitinder Kaur · Tulane University Of Louisiana$12,771,713
- Gary Fanger · Rise Therapeutics, Llc$12,156,047
- Afonso C Silva · University Of Pittsburgh At Pittsburgh$9,841,960
Research focus
CytokineResponseT-LymphocytePathogenImmunityBacteriaPreventImmuneChildLymphocyteBioinformaticsLifeMediatingTissuesCellsIn VivoCharacteristicsInnovationProductionMucous MembraneFungusMicrobialInflammatoryInfectious Skin Diseases
Grant awards (7)
Innate lymphocyte responses to early-life infections$460,000
R35 · FY2025 · GM · contact PI
Innate lymphocyte responses to early-life infections$460,000
R35 · FY2024 · GM · contact PI
Innate lymphocyte responses to early-life infections$452,500
R35 · FY2023 · GM · contact PI
Modulation of in vivo MAIT cell responses with diverse MR1 ligands$221,875
R21 · FY2023 · AI · contact PI
Modulation of in vivo MAIT cell responses with diverse MR1 ligands$266,250
R21 · FY2022 · AI · contact PI
Crosstalk between MAIT cells and the microbiota$108,000
K22 · FY2022 · AI · contact PI
Crosstalk between MAIT cells and the microbiota$162,000
K22 · FY2021 · AI · contact PI